Brief CommunicationLack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter
References (19)
- et al.
Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein
Neurosci. Lett.
(1999) - et al.
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model
Cell
(1991) - et al.
5′ flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice
J. Neurosci.
(1992) - et al.
Pathoanatomy of Parkinson's disease
J. Neurol.
(2000) - et al.
(+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice
J. Pharmacol. Exp. Ther.
(1997) - et al.
A Drosophila model of Parkinson's disease
Nature
(2000) - et al.
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease—Neuropathologic considerations
Adv. Neurol.
(1993) - et al.
Studies of human α-synuclein in transgenic mice
Abstr. Soc. Neurosci.
(2000) - et al.
Subcellular localization of wild-type and Parkinson's disease-associated mutant α-synuclein in human and transgenic mouse brain
J. Neurosci.
(2000)
There are more references available in the full text version of this article.
Cited by (250)
Review: Lower urinary tract dysfunction in animal models of Parkinson's disease (PD): Translational aspects for the treatment of PD patients with overactive bladder
2024, International Review of NeurobiologyPET imaging in animal models of Parkinson's disease
2023, Behavioural Brain ResearchImpact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
2022, Journal of Pharmacological SciencesModeling with the A53T α-synuclein model of Parkinson’s disease
2020, Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2
- 1
These authors contributed equally to this work.
Copyright © 2001 Academic Press. All rights reserved.